FDA/CMS Summit | Expanding the Role of RWE and PROs in Regulatory Decision-Making

At the FDA/CMS Summit on Tuesday, December 3, NESTcc Data Network Director Robert Zusterzeel, MD, PhD, MPH, joins a panel session titled Expanding the Role of RWE and PROs in Regulatory Decision-Making.

Panel Summary


  • Cathy W. Critchlow, PhD
    Vice President, Center for Observational Research
    Amgen, Inc.


  • David Martin
    Associate Director, Real World Evidence Analytics,
    Office of Medical Policy, CDER
    U.S. Food and Drug Administration (FDA)
  • Karin Van Baelen
    Head, Global Regulatory Affairs
    Janssen, Pharmaceutical Companies of Johnson & Johnson
  • Robbert Zusterzeel, MD, PhD, MPH
    Data Network Director
    NEST Coordinating Center (NESTcc)
  • James Reimann
    Vice President, Global Head Oncology, Biostatistics


Westin Arlington Gateway
801 North Glebe Road
Arlington, VA 22203